Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

34 recalls, newest first

Class III · Low risk

Sodium Chloride Ophthalmic Ointment USP

Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Terminated Particulate / foreign matter Akorn, Inc. NDC 17478-622-35 D-0859-2020
Class II · Moderate risk

Major Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 0904-6730-60 D-0858-2020
Class II · Moderate risk

Leader Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 7000-0036-1 D-0857-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

Terminated Particulate / foreign matter Graviti Pharmaceuticals Private Limited NDC 70377-027-11 D-0832-2020

Recalls by year